HALIX collaborates with AstraZeneca for commercial manufacture of COVID-19 vaccine

▴ HALIX collaborates with AstraZeneca for commercial manufacture of COVID-19 vaccine
The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech

HALIX B.V. signed an agreement with AstraZeneca AB for large-scale commercial drug substance manufacture of AZD1222, the adenovirus vector-based COVID-19 vaccine.

Under the agreement, HALIX will provide commercial manufacturing of drug substance at its state-of-the-art cGMP facility at the Leiden Bio Science Park in the Netherlands. To meet the increased demand, HALIX expands with two additional viral vector production lines.

With this agreement, HALIX continues its key role as one of the original partners in the University of Oxford’s consortium for the manufacture of AZD1222. The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech.

Alex Huybens, Chief Operations Officer, states, “Building on the solid foundations made with the University of Oxford, it’s our pleasure to expand our manufacturing support of AZD1222 with AstraZeneca. Through the consortium, the partners are bringing their collective expertise and manufacturing capabilities to support vaccine production and combat this evolving crisis.”

HALIX has an established technical and quality track record for the development and GMP manufacture of viral vectors used in immuno-oncology and to vaccinate against infectious diseases, such as HIV, ZIKA, Chikungunya and the Influenza. The 6,700 m2 BSL2 GMP facility, recently approved by the Dutch authorities and located on the Leiden Bio Science Park in the Netherlands, provides both clinical and commercial-scale manufacturing capabilities in fully independent, self-contained Grade B and C cleanrooms for virus products.

Tags : #HALIX #LatestNewsonHALIX #AstraZeneca #LatestNewsonAstraZeneca12thDec #LatestPharmaCollaboration12thDec #LatestPharmaNews12thDec #LatestNewsonCOVIDVaccine12thDec #UniversityofOxford

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Advancing Healthcare Access: ScreenHer initiative in Pakistan close to reaching milestone of 20,000 diabetes screenings in 70 clinics February 26, 2024
FICCI Ladies Organization organized an interaction with one of the doyens of Indian IT industry Dr BVR Mohan ReddyFebruary 26, 2024
Former Secretary General of SCSC, Krishna Yedula conferred with Doctorate in HumanityFebruary 25, 2024
Project Champion School Games held February 25, 2024
Daksha 3.0, a nation level techno-test organised by Anurag University concludedFebruary 25, 2024
Mechanisation of Visakhapatnam Port is almost completeFebruary 24, 2024
Recovery Process After Contoura Surgery: Tips and Insights from an ExpertFebruary 24, 2024
Understanding Age-Related Macular Degeneration (AMD) and the Role of NutritionFebruary 24, 2024
Impact of Alcohol Consumption on Eye Health: Insights from a Senior Cataract SurgeonFebruary 23, 2024
Better health of healthcare workers in India : A Closer Look” Insights by Dr. Gopal Sharan MD & CEO of TRLS Healthcare ConsultancyFebruary 23, 2024
Chandrayaan Soft landing of India sent a strong message to the world not to take Indians light: Dr Prakash Chauhan, Director National Remote Sensing CenterFebruary 23, 2024
Dr Raj Nagarkar Leads Master Class On Robotic Surgery For Postgraduates At MASICON 2024 In NashikFebruary 23, 2024
Nanhaagyan Foundation Illuminates Pune with the Resplendent Healing Light Awards 2024February 23, 2024
Anifest India 2024: Pioneering Creativity in Pune's Animation Landscape"February 23, 2024
A Tie with a difference, promoting a cause, 17 SDGs of UNFebruary 22, 2024
Worldwide EndoMarch, Endo Run to raise mass awareness on Endometriosis!February 21, 2024
Uptick In Respiratory, and Cardiac Problems Due To Poor Air Quality In DelhiFebruary 21, 2024
Evidence shows risks associated with energy drinks in childrenFebruary 21, 2024
iHub-Data at IT-Hyderabad announces collaborative initiative with technical institutions for AI/ML training programsFebruary 20, 2024
Viatris Receives Global Minimized Risk of Antimicrobial Resistance Certification, Advancing its Commitment to Responsible Antibiotic ProductionFebruary 20, 2024